Showing results (31-40 of 2,510) with videos related to
Sort By:
Pageof 251
Inflammopharmacology|November 28, 2024
Shedding light on microglial dysregulation in Alzheimer's disease: exploring molecular mechanisms and therapeutic avenuesVanshu Bhardwaj, Sneha Kumari, Rishika Dhapola, et al.Inflammopharmacology|November 15, 2024
Pathophysiological role of high mobility group box-1 signaling in neurodegenerative diseasesVishal Kumar, Puneet KumarInflammopharmacology|November 14, 2024
The multifaceted anticancer potential of luteolin: involvement of NF-κB, AMPK/mTOR, PI3K/Akt, MAPK, and Wnt/β-catenin pathwaysDeepika Singh, Gaurav ShuklaInflammopharmacology|November 20, 2024
Quercetin alleviates neonatal hypoxic-ischaemic brain injury by rebalancing microglial M1/M2 polarization through silent information regulator 1/ high mobility group box-1 signallingZhaoyan Chen, Fei Ruan, Di Wu, et al.Inflammopharmacology|November 22, 2024
Recent advancements in drug delivery system of flavonoids with a special emphasis on the flavanone naringenin: exploring their application in wound healing and associated processesAnkit Chowdhury, Bapi Gorain, Papiya Mitra MazumderInflammopharmacology|February 26, 2025
Dissolving microneedle patch for transdermal delivery of perindopril erbumineZunaira Altaf, Zulcaif Ahmad, Asif Mahmood, et al.Inflammopharmacology|February 27, 2025
Unravelling the prophylactic anti-inflammatory potential of Koenigia tortuosa through modulation of cytokine levels and inflammatory markers in LPS-induced localized inflammation in Wistar rat modelsAmbreena Farooq, Mudasar Nabi, Khalid Bashir Dar, et al.Inflammopharmacology|February 20, 2025
The angiotensin II type 2 receptor antagonists, PD123,319 ((S-( +)-1-[(4-(dimethylamino)-3-methylphenyl)methyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid), EMA300 (5-(2,2-diphenylacetyl)-4-[(4-methoxy-3-methylphenyl)methyl]-1,4,6,7-tetrahydroimidazo[4,5-c]pyridine-6-carboxylic acid) and EMA401 ((3S)-5-(benzyloxy)-2-(2,2-diphenylacetyl)-6-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid), evoke pain relief in a varicella zoster virus-induced rat model of neuropathic painV Das, A L Lam, M T SmithInflammopharmacology|November 5, 2024
Therapeutic applications of eucalyptus essential oilsRiham A El Shiekh, Ahmed M Atwa, Ali M Elgindy, et al.Inflammopharmacology|October 29, 2024
Cyclosporin for the treatment of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN): a systematic review of observational studies and clinical trials focusing on single therapy, combination therapy, and comparative assessmentsAmirhossein Nazerian, Alireza Jafarzadeh, Sadaf Salehi, et al.Pageof 251